 Monkeypox stocks, our topic for today, have had a mostly mixed performance so far in 2022. It is likely, however, that they could benefit from the similar tailwinds enjoyed by companies, such as Pfizer NYSE: PFE , BioNTech NASDAQ: BNTX , and Moderna NASDAQ: MRNA , which have developed the Covid-19 vaccines that have now become household names. 